373 related articles for article (PubMed ID: 29276218)
1. Signal Diversity of Receptor for Advanced Glycation End Products.
Sakaguchi M; Kinoshita R; Putranto EW; Ruma IMW; Sumardika IW; Youyi C; Tomonobu N; Yamamoto KI; Murata H
Acta Med Okayama; 2017 Dec; 71(6):459-465. PubMed ID: 29276218
[TBL] [Abstract][Full Text] [Related]
2. DNAX-activating protein 10 (DAP10) membrane adaptor associates with receptor for advanced glycation end products (RAGE) and modulates the RAGE-triggered signaling pathway in human keratinocytes.
Sakaguchi M; Murata H; Aoyama Y; Hibino T; Putranto EW; Ruma IM; Inoue Y; Sakaguchi Y; Yamamoto K; Kinoshita R; Futami J; Kataoka K; Iwatsuki K; Huh NH
J Biol Chem; 2014 Aug; 289(34):23389-402. PubMed ID: 25002577
[TBL] [Abstract][Full Text] [Related]
3. TIRAP, an adaptor protein for TLR2/4, transduces a signal from RAGE phosphorylated upon ligand binding.
Sakaguchi M; Murata H; Yamamoto K; Ono T; Sakaguchi Y; Motoyama A; Hibino T; Kataoka K; Huh NH
PLoS One; 2011; 6(8):e23132. PubMed ID: 21829704
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of RAGE signaling through the intracellular delivery of inhibitor peptides by PEI cationization.
Putranto EW; Murata H; Yamamoto K; Kataoka K; Yamada H; Futami J; Sakaguchi M; Huh NH
Int J Mol Med; 2013 Oct; 32(4):938-44. PubMed ID: 23934084
[TBL] [Abstract][Full Text] [Related]
5. Modulation of leukotriene B4 receptor 1 signaling by receptor for advanced glycation end products (RAGE).
Ichiki T; Koga T; Okuno T; Saeki K; Yamamoto Y; Yamamoto H; Sakaguchi M; Yokomizo T
FASEB J; 2016 May; 30(5):1811-22. PubMed ID: 26813973
[TBL] [Abstract][Full Text] [Related]
6. Involvement of formyl peptide receptors in receptor for advanced glycation end products (RAGE)--and amyloid beta 1-42-induced signal transduction in glial cells.
Slowik A; Merres J; Elfgen A; Jansen S; Mohr F; Wruck CJ; Pufe T; Brandenburg LO
Mol Neurodegener; 2012 Nov; 7():55. PubMed ID: 23164356
[TBL] [Abstract][Full Text] [Related]
7. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways.
Huttunen HJ; Fages C; Rauvala H
J Biol Chem; 1999 Jul; 274(28):19919-24. PubMed ID: 10391939
[TBL] [Abstract][Full Text] [Related]
8. Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42.
Hudson BI; Kalea AZ; Del Mar Arriero M; Harja E; Boulanger E; D'Agati V; Schmidt AM
J Biol Chem; 2008 Dec; 283(49):34457-68. PubMed ID: 18922799
[TBL] [Abstract][Full Text] [Related]
9. Cellular signalling of the receptor for advanced glycation end products (RAGE).
Xie J; Méndez JD; Méndez-Valenzuela V; Aguilar-Hernández MM
Cell Signal; 2013 Nov; 25(11):2185-97. PubMed ID: 23838007
[TBL] [Abstract][Full Text] [Related]
10. Homodimerization is essential for the receptor for advanced glycation end products (RAGE)-mediated signal transduction.
Zong H; Madden A; Ward M; Mooney MH; Elliott CT; Stitt AW
J Biol Chem; 2010 Jul; 285(30):23137-46. PubMed ID: 20504772
[TBL] [Abstract][Full Text] [Related]
11. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation.
Huttunen HJ; Kuja-Panula J; Sorci G; Agneletti AL; Donato R; Rauvala H
J Biol Chem; 2000 Dec; 275(51):40096-105. PubMed ID: 11007787
[TBL] [Abstract][Full Text] [Related]
12. Every Cloud Has a Silver Lining: Proneurogenic Effects of Aβ Oligomers and HMGB-1 via Activation of the RAGE-NF-κB Axis.
Bortolotto V; Grilli M
CNS Neurol Disord Drug Targets; 2017; 16(10):1066-1079. PubMed ID: 27488419
[TBL] [Abstract][Full Text] [Related]
13. RAGE in tissue homeostasis, repair and regeneration.
Sorci G; Riuzzi F; Giambanco I; Donato R
Biochim Biophys Acta; 2013 Jan; 1833(1):101-9. PubMed ID: 23103427
[TBL] [Abstract][Full Text] [Related]
14. Glycation reaction and the role of the receptor for advanced glycation end-products in immunity and social behavior.
Leerach N; Harashima A; Munesue S; Kimura K; Oshima Y; Goto H; Yamamoto H; Higashida H; Yamamoto Y
Glycoconj J; 2021 Jun; 38(3):303-310. PubMed ID: 33108607
[TBL] [Abstract][Full Text] [Related]
15. The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site.
Ishihara K; Tsutsumi K; Kawane S; Nakajima M; Kasaoka T
FEBS Lett; 2003 Aug; 550(1-3):107-13. PubMed ID: 12935895
[TBL] [Abstract][Full Text] [Related]
16. [Role of the receptor for advanced glycation end products (RAGE) in inflammation].
Mosquera JA
Invest Clin; 2010 Jun; 51(2):257-68. PubMed ID: 20928981
[TBL] [Abstract][Full Text] [Related]
17. Role of advanced glycation end products in cellular signaling.
Ott C; Jacobs K; Haucke E; Navarrete Santos A; Grune T; Simm A
Redox Biol; 2014; 2():411-29. PubMed ID: 24624331
[TBL] [Abstract][Full Text] [Related]
18. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).
van Beijnum JR; Buurman WA; Griffioen AW
Angiogenesis; 2008; 11(1):91-9. PubMed ID: 18264787
[TBL] [Abstract][Full Text] [Related]
19. Understanding RAGE, the receptor for advanced glycation end products.
Bierhaus A; Humpert PM; Morcos M; Wendt T; Chavakis T; Arnold B; Stern DM; Nawroth PP
J Mol Med (Berl); 2005 Nov; 83(11):876-86. PubMed ID: 16133426
[TBL] [Abstract][Full Text] [Related]
20. Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis.
Leung SS; Forbes JM; Borg DJ
Curr Diab Rep; 2016 Oct; 16(10):100. PubMed ID: 27612847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
